Healthcare Under Siege

Showing 3456 articles
Business

Hercules Capital: A Hidden Gem in High-Growth Financing?

Hercules Capital (HTGC), a key lender to venture-backed companies, appears significantly undervalued by traditional metrics. With shares trading at a discount to intrinsic value and below peer multiples, the market may be overlooking its strategic role and earnings potential.

Business

Zegna Charts Steady Course Amid Leadership Shift and China Volatility, Fueled by DTC Momentum

The Ermenegildo Zegna Group reported a resilient 2025, with full-year revenues reaching €1.92 billion. A strong fourth-quarter acceleration, driven by a 10% surge in direct-to-consumer sales, underscores the luxury group's strategic pivot away from wholesale. While the Americas and EMEA regions showed robust growth, Greater China remains a volatile market as the company navigates a planned leadership transition and industry headwinds.

Business

ExxonMobil Defies Oil Slump with Aggressive $20 Billion Buyback, Signals Unwavering Dividend Commitment

While the energy sector retrenched amid falling crude prices, ExxonMobil executed a massive $20 billion share repurchase program in 2025, underlining its financial muscle and commitment to shareholder returns. The oil giant also reported earnings that beat estimates, driven by record production in the Permian Basin and Guyana, even as it takes a hardline stance on reinvesting in Venezuela.

Business

Sea Limited's Stock Plunge: A Buying Opportunity or a Value Trap?

Sea Limited's shares have tumbled over 11% year-to-date, sparking debate among investors. While a discounted cash flow model suggests the stock is deeply undervalued, its lofty P/E ratio tells a more cautious tale. We examine the conflicting signals and what they mean for the Southeast Asian tech giant's future.